Chemerin is a new adipokine associated with obesity and the metabolic syndrome 1, which is correlated with inflammatory cytokines, such as high-sensitivity C-reactive protein, interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) 2. This evidence concerns the gene IL6 and obesity disorder.